10:37 AM EST, 11/06/2025 (MT Newswires) -- Moderna ( MRNA ) narrowed its full-year revenue outlook on Thursday as the drugmaker's third-quarter top-line declined less than expected amid weak COVID-19 vaccine sales.

The company now anticipates revenue to come in between $1.6 billion and $2 billion for 2025, compared with its previous guidance of $1.5 billion to $2.2 billion. The consensus on FactSet is for sales of $1.89 billion.

Moderna ( MRNA ) expects sales in the US to range from $100 million to $400 million for the ongoing quarter, bringing its full-year revenue outlook to between $1 billion and $1.3 billion versus the prior forecast of $1 billion to $1.5 billion, Chief Financial Officer Jamey Mock said during an earnings conference call, according to a FactSet transcript.

Retail COVID-19 vaccinations in the US plunged about 30% year-over-year as of Oct. 24, in line with the 20% to 40% decline previously projected for 2025, Chief Executive Stephane Bancel told analysts.

International revenue is pegged at $300 million to $400 million in the fourth quarter, bringing the 2025 guidance to $600 million to $700 million, an upgrade to the bottom end of the range, Mock said on the call.

"We have a tighter range on our international sales as most of these sales are for contracted volumes, leaving delivery timing, and file vaccination rates as the only remaining variables," the CFO added.

For the quarter ended Sept. 30, revenue plunged 45% to $1.02 billion due to lower COVID-19 vaccine sales, but came in ahead of the average analyst estimate of $879.6 million. Product sales tumbled 47% to $973 million, Moderna ( MRNA ) said.

The company reported a net loss of $0.51 per share, swinging from earnings of $0.03 the year before.

Moderna's ( MRNA ) shares advanced 3.9% in Thursday trade. The stock has lost 41% so far this year.

Moderna ( MRNA ) doesn't expect newly introduced tariffs to have a "material impact" on its business, while it continues to monitor changes to global tariffs, Mock told analysts on the call.

Price: 23.84, Change: +0.28, Percent Change: +1.19